Figure 2From: Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study DXR-MCI loss in the methotrexate (MTX) plus adalimumab and MTX groups according to CRP level achieved.Back to article page